The chief findings of this study, undertaken in a single centre multiethnic cohort, are that increased disease activity in Asian SLE patients, as measured by PAD, is associated with increased serum MIF but not Type I IFN induced chemokines, and that increased PAD in Asian SLE patients is also driven by factors independent of these two pathways. The gene discussed is MIF; the disease is peripheral arterial disease.